Literature DB >> 8541111

p53 in malignant and benign liver lesions.

Z Schaff1, I Sárosi, C C Hsia, A Kiss, E Tabor.   

Abstract

p53 expression was studied by immunohistochemical methods in benign and malignant human epithelial liver lesions in 46 patients from Hungary. Positive immunostaining for p53 protein, indicating the overexpression or prolonged half-life of p53 protein, was detected in the nuclei of tumour cells of seven of the 16 hepatocellular carcinomas (HCC) (44%), including three HCC patients with hepatitis B virus infection. Immunostaining of p53 was seen in one of the seven hepatoblastomas, none of the 17 focal nodular hyperplasias, and none of the six hepatocellular adenomas. The detection of p53 in a relatively high percentage of the HCC cases in Hungary, a country in which aflatoxin contamination of the diet is rare, suggests that factors other than aflatoxin led to the accumulation or overexpression of p53 in these patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541111     DOI: 10.1016/0959-8049(95)00380-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

Review 1.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

2.  Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.

Authors:  L W Elmore; A R Hancock; S F Chang; X W Wang; S Chang; C P Callahan; D A Geller; H Will; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

3.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.